Description The purpose of this best practice advice (BPA) article from the Clinical Practice
Update Committee of the American Gastroenterological Association is to provide an update …

Importance Barrett esophagus, a complication of gastroesophageal reflux disease (GERD),
predisposes patients to esophageal adenocarcinoma, a tumor that has increased in …

Barrett's esophagus (BE) is among the most common conditions encountered by the
gastroenterologist. In this document, the American College of Gastroenterology updates its …

These guidelines provide a practical and evidence-based resource for the management of
patients with Barrett's oesophagus and related early neoplasia. The Appraisal of Guidelines …

Objective Reported malignant progression rates for low-grade dysplasia (LGD) in Barrett's
oesophagus (BO) vary widely. Expert histological review of LGD is advised, but limited data …

Background and aims Acid-suppressive medications, particularly proton pump inhibitors
(PPIs), may decrease the risk of oesophageal adenocarcinoma (OAC) in patients with …

Barrett's esophagus (BE) is a condition in which the typical squamous epithelium of the
esophageal mucosa is replaced with columnar intestinal epithelium. 1, 2 BE is a known …

BACKGROUND & AIMS: Esophageal adenocarcinoma (EA) is increasingly common among
patients with Barrett's esophagus (BE). We aimed to provide consensus recommendations …

Background & Aims In patients with Barrett's esophagus (BE), radiofrequency ablation (RFA)
safely and effectively eradicates dysplasia and intestinal metaplasia. We aimed to determine …

61 literature when available. When data were unavailable to support establishing a
performance target level,“N/A”(not available) was listed. However, when expert consensus …